Australian-backed investment to support global commercial scale-up of HyperVIEW™ across healthcare and mining industrial applications Australia, June 2026 - Hancock Prospecting has provided an initial US$50 million investment into Lumitron, with the right to increase its investment to US$100 million during the 2026 calendar year. The funding will support the commercial scale-up and deployment of the company’s HyperVIEW™ Very High Energy Electron (VHEE) beam and advanced X-ray

On April 22, Lumitron’s co-founder and CTO, Dr. Chris Barty, presented one of three plenary lectures at this years Optics and Photonics International Congress (OPIC) in Yokohama, Japan. OPIC and the associated Optics and Photonics International Exhibition (OPIE) brings together several thousand attendees annually spanning virtually all optics and photonics related industries and science. Dr. Barty’s lecture introduced the core, patented, accelerator and laser technologies w

A Southern California company called Lumitron has developed a new kind of x-ray system. It uses advanced electron beam technology to see cancer at a cellular level. This system called "hyper-view" can deliver ultra-detailed images with up to one-thousand times more clarity than standard x-rays while using 100-times less radiation. The technology could make cancer treatment safer and more effective. Founder of Lumitron, Dr. Chris Barty explains how it all works and the benefit

Recent study concludes Lumitron’s laser-Compton X-ray source can improve tumor detection by more than 3000% relative to today’s standards Irvine, CA - Contrast-enhanced mammography (CEM) using traditional X-ray tubes is an advanced imaging technique that improves breast cancer detection rates, particularly for patients with dense or thick breast tissue. According to simulations published recently in Medical Physics, Lumitron's HyperVIEW™ has the ability to improve upon existi

FDA Grants Designation